Genzyme Corporation
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents785
SAM.gov UEIX2XMAQLR9DA8
CAGE code1HBD8
Incorporated inMA
LEI549300ZNNO34O8GXUE47
- rare diseases
- vaccines
- North America
- artificial intelligence
- development
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
785 US patents granted 1987–2025, 176 of them in the five years to SEP 2025, including 13 design patents.
Pharmaceuticals 449Medical technology 97Biotechnology 91Organic fine chemistry 52Measurement 44
- Needle shroud latch for injection devicesUS 12,427,266 · granted SEP 30, 2025
- Hold assistance deviceUS 12,427,265 · granted SEP 30, 2025
- Damping device for a medicament delivery deviceUS 12,420,017 · granted SEP 23, 2025
- Medicament delivery deviceUS 12,409,277 · granted SEP 9, 2025
- Medicament delivery deviceUS 12,403,266 · granted SEP 2, 2025
Newest 5 shown · Granted to Genzyme Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Genzyme Corporation | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.